Loading items....
Funding Opportunities
The University of Colorado Anschutz Cancer Center is pleased to offer pilot grant funding to support the development of exceptional research projects leading to the ultimate conquest of cancer and furthering cancer center objectives.
Sign up to receive weekly updates on Intramural & Extramural Funding Opportunities.
Current Open RFAs
Across the Finish Line
Developed in collaboration with Cancer Center Programs and the Associate Director for Basic Research, the Across the Finish Line (CC‑AFL) mechanism provides targeted funding to help investigators address reviewer comments on NCI, NIH, and other nationally peer-reviewed grant applications that narrowly missed the pay line. This RFA is not intended as bridge funding; rather, it provides targeted support to strengthen and enhance the competitiveness of resubmitted applications.
Eligibility: Open to Cancer Center members with a cancer-focused grant application that fell just short of funding. Projects should be task-driven and focused on specific actions required to address reviewers' comments and improve the overall competitiveness of a resubmitted grant. A1 applications are not eligible. Preference will be given to multi-PI and multi-project proposals.
Funding: Up to $30,000 for single-PI proposals and up to $50,000 for MPI proposals. Funds will be awarded for a 1-year project period (12/1/26- 12/1/27) and the revised grant must be resubmitted to a national peer-reviewed program before the end of the 1-year funding period.
Cancer Center Internal submission deadline: 5:00 pm MT on Friday, October 16.
Cancer Center Nomination Notification: The week of November 16.
Please review all eligibility requirements and application instructions in the link below before applying.
V Foundation
Adult Translational Cancer Research Award
This grant opportunity is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies.
Research on ANY adult cancer type is eligible. Projects may advance a novel strategy toward a clinical trial or use clinical trial specimens to develop biomarkers, test hypotheses, or investigate disease mechanisms. Proposed research must have a clear path to human application within three years of grant completion. A detailed biostatistical or bioinformatics plan is required.
Eligibility: Applicants must have a full-time faculty position at the rank of Assistant Professor (or equivalent) or higher.
Funding: $800,000 over four years ($200,000 per year)
Cancer Center LOI Deadline: 5:00 pm MT on Friday, October 16.
Cancer Center Nomination Notification: No later than the week of November 30. One applicant will be nominated.
Anticipated Sponsor Deadline: January 8, 2027.
Please review the RFA and internal LOI submission link below for complete eligibility requirements and application instructions.